- 现金
- 2481 元
- 精华
- 5
- 帖子
- 855
- 注册时间
- 2002-3-30
- 最后登录
- 2012-7-8
|
[全球丙型肝炎协会]今天载文报道新华网刊登的一条海外新闻. 文中中国科学研究人员, 地毯医生徐道征(译音)等描述的全国最新统计显示, 目前中国感染丙型病毒肝炎的群族正在快速发展, 达到4千1百万.
和乙肝不同的是75%的患者没有症状感觉. 感染群中15%将会转换肝脏硬化, 5%会变异肝癌. 如果对此不重视, 不讲丙型肝炎作文常规体检项目, 它会和目前乙肝一样造成中国社会问题!!!
对于丙型肝炎目前还没有疫苗可以预防. 中国医学学会强调应该将丙型肝炎作为普通检查项目的常规, 特别是对高危险感染人们.
目前中国13亿人口中大约有2亿人口感染慢性病毒性肝炎, 半数28万肝病患者因为病变肝癌死亡.
原文:
[B]41 million Chinese believed to have hepatitis C virus: report[/B]
Source URL:http://news.xinhuanet.com/www.chinaview.cn
BEIJING, June 26 (Xinhuanet) -- An estimated 41 million people in China have contracted the hepatitis C virus, which could become a fatal "quiet epidemic," according to Professor Xu Daozheng, a liver disease expert with Ditan Hospital in Beijing.
The Chinese Ministry of Health said in a report, issued in February, the number of hepatitis C patient was growing. A national epidemiological survey covering the 1992-1995 period found 3.2 percent of the country's population, or 38 million people, had hepatitis C virus.
Prof. Xu said his estimate is quite conservative, and suggested the disease should be included in normal medical checks, like hepatitis B, because it has become a serious public health issue in China.
At present, a patient with hepatitis C may look normal and feel just as good as a healthy person, and the disease will not be detected until it is too late, the professor warned.
Unlike other types of hepatitis B, 75 percent of people with hepatitis C show no signs of symptoms in the early stage, said Xu.
About 15 percent of the people with hepatitis C will develop hepatocirrhosis and 5 percent would develop cancer if the disease is detected in a later stage, the expert explained.
There is still no vaccine against hepatitis C in China, and the China Medical Association has called for screening the disease in normal blood tests, especially among high-risk groups.
China has about 20 million people with chronic viral liver diseases out of its 1.3 billion population, and half of the 280,000 patients of liver disease died of liver cancer. |
|